Quercetin consistently attenuates oxidative stress and inflammation, modulating immune pathways in autoimmune diseases
Background
Autoimmune diseases are chronic conditions marked by immune tolerance loss, leading to chronic inflammation, tissue damage, and organ dysfunction. Current therapies often have significant adverse effects and limited long-term efficacy. Quercetin, a natural flavonoid, is being explored for its antioxidant, anti-inflammatory, and immunomodulatory properties, offering a potential alternative to address these therapeutic gaps by targeting underlying immune dysregulation.
Study Design
This systematic review evaluated preclinical (in vitro human-derived cell models) and human clinical (in vivo) studies on quercetin's effects in autoimmune conditions. Researchers searched PubMed, Scopus, and Cochrane Library for English-language papers published from 2014 onwards, excluding reviews and studies lacking mechanistic insights. Manual reference screening supplemented database searches. A total of thirteen studies were included for qualitative synthesis, focusing on pharmacological effects and therapeutic potential.
Results
Quercetin consistently exhibited beneficial effects across the included studies. It significantly attenuated oxidative stress and suppressed various pro-inflammatory cytokines, including those involved in Th17 cell responses, as highlighted by a related study targeting the RELA/c-Jun axis. The flavonoid also modulated several immune-related signaling pathways, contributing to its overall immunomodulatory profile.
Several clinical studies within the review reported that quercetin alleviated disease severity and reduced tissue inflammation, underscoring its therapeutic potential in human autoimmune conditions. These pleiotropic mechanisms collectively support quercetin's protective role against immune dysregulation and chronic inflammation characteristic of autoimmune diseases.
Key Findings
- Quercetin consistently attenuated oxidative stress in autoimmune models.
- Quercetin suppressed pro-inflammatory cytokines across studies.
- Quercetin modulated immune-related signaling pathways.
- Clinical studies reported quercetin alleviated disease severity.
- Quercetin reduced tissue inflammation in human autoimmune conditions.
Why It Matters
Quercetin emerges as a promising adjunctive or alternative therapy for autoimmune diseases, potentially mitigating the side effects and limited efficacy of current treatments. While direct human protocols are still nascent, the consistent preclinical and early clinical findings suggest that incorporating quercetin could improve patient outcomes by targeting inflammation and oxidative stress. Further standardized clinical trials are crucial to define optimal dosing, routes, and long-term safety profiles before widespread clinical adoption. For biohackers, this reinforces quercetin's potential as a natural compound for immune support, though specific autoimmune protocols require professional guidance.
quercetin
autoimmune-diseases
inflammation
oxidative-stress
immunomodulation
systematic-review